Literature DB >> 16344502

Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis.

S M J Harney, J Timperley, C Daly, A Harin, T James, M A Brown, A P Banning, K Fox, S Donnelly, B P Wordsworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16344502      PMCID： PMC1797986          DOI： 10.1136/ard.2005.040634

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

Review 1.  Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

Authors:  Hilal Maradit-Kremers; Cynthia S Crowson; Paulo J Nicola; Karla V Ballman; Véronique L Roger; Steve J Jacobsen; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-02

Review 2.  Measurement and significance of circulating natriuretic peptides in cardiovascular disease.

Authors:  G A Sagnella
Journal:  Clin Sci (Lond)       Date:  1998-11       Impact factor: 6.124
  2 in total
  8 in total

1.  N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?

Authors:  Thomas Häupl; Gerd R Burmester; Evangelos Giannitsis; Thorsten Rohrlach; Eberhard Spanuth; Hans Parsch; Kay Brune
Journal:  Ann Rheum Dis       Date:  2007-06       Impact factor: 19.103

2.  Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.

Authors:  Cynthia S Crowson; Elena Myasoedova; John M Davis; Veronique L Roger; Barry L Karon; Daniel Borgeson; Richard J Rodeheffer; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-05       Impact factor: 4.794

3.  Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.

Authors:  Bożena Targońska-Stępniak; Maria Majdan
Journal:  Clin Rheumatol       Date:  2010-11-26       Impact factor: 2.980

4.  A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-06

5.  B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?

Authors:  Omer Karadag; Meral Calguneri; Bunyamin Yavuz; Enver Atalar; Ali Akdogan; Umut Kalyoncu; Sedat Kiraz; Serdar Aksoyek; Ferhan Ozmen; A Ihsan Ertenli
Journal:  Clin Rheumatol       Date:  2007-02-21       Impact factor: 2.980

6.  Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.

Authors:  Joseph Solus; Cecilia P Chung; Annette Oeser; Ingrid Avalos; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Tuulikki Sokka; Theodore Pincus; C Michael Stein
Journal:  Arthritis Rheum       Date:  2008-09

7.  Left ventricular morphology and function in patients with rheumatoid arthritis.

Authors:  L'ubomír Tomáš; Ivica Lazúrová; Mária Oetterová; Lýdia Pundová; Darina Petrášová; Martin Studenčan
Journal:  Wien Klin Wochenschr       Date:  2013-04-12       Impact factor: 1.704

8.  The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.

Authors:  Sella A Provan; Kristin Angel; Sigrid Odegård; Petter Mowinckel; Dan Atar; Tore K Kvien
Journal:  Arthritis Res Ther       Date:  2008-06-23       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.